Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Analysis of phase II and phase III clinical trial terminations from 2013 to 2023. — SciRadar

Back to results

Nature reviews. Drug discovery

Analysis of phase II and phase III clinical trial terminations from 2013 to 2023.

Heather Bowling, Arianna Cocucci, Da Chen Emily Koo, Richard K Harrison

Published: 202510.1038/d41573-025-00208-6

No abstract available for this study.